What's new in bacterial vaginosis and trichomoniasis?

Infect Dis Clin North Am. 2005 Jun;19(2):387-406. doi: 10.1016/j.idc.2005.03.001.


The use of biochemical profiles and new molecular microbiologic methodologies is transforming our understanding of BV. Most important is the recognition of different subgroups of women who have BV who are at variable risk of certain obstetric and gynecologic complications. New diagnostic tests may soon be available that will allow women to test self-obtained specimens. Treatment of BV has lagged, although innovative methods appear to be helpful in managing recurrent diseases.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Pregnancy
  • Pregnancy Complications, Infectious / etiology
  • Pregnancy Complications, Infectious / physiopathology
  • Prevalence
  • Trichomonas Infections* / diagnosis
  • Trichomonas Infections* / epidemiology
  • Trichomonas Infections* / physiopathology
  • United States / epidemiology
  • Vaginosis, Bacterial* / diagnosis
  • Vaginosis, Bacterial* / epidemiology
  • Vaginosis, Bacterial* / physiopathology


  • Anti-Infective Agents